Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Apply
Deucravacitinib vs. Ustekinumab
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step